Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Autoimmune Encephalitis

Seronegative Autoimmune Encephalitis: Need a Brain Biopsy?

At a Glance

A negative antibody panel does not by itself mean a brain biopsy is needed in seronegative autoimmune encephalitis. Specialists usually combine symptoms, MRI, EEG, spinal fluid, broader antibody testing, and evaluation for tumors or infections before considering an invasive biopsy.

A brain biopsy is not routinely required to diagnose probable seronegative (antibody-negative) autoimmune encephalitis [1]. A negative antibody panel does not automatically mean a biopsy is the next step. Instead, “antibody-negative” simply means no recognized disease-associated antibody was detected on the tests performed [2]. In most cases, doctors make a clinical diagnosis based on a subacute onset of specific symptoms, brain imaging (MRI), EEG (electroencephalogram, a test that records the brain’s electrical activity), spinal fluid analysis (CSF), and the careful exclusion of other diseases [1].

Because brain biopsies are invasive and carry risks, they are reserved for exceptional situations where a multidisciplinary specialist team cannot otherwise safely rule out a dangerous mimic [3].

Broader Testing Before a Biopsy

When a standard commercial antibody panel comes back negative, experts typically first recommend broader testing [2]. This often involves sending paired blood and CSF samples to specialized laboratories. These labs use broad tissue-based testing (where your fluid is applied to animal brain tissue to see if antibodies react) and cell-based assays, which can sometimes detect antibodies that standard commercial panels miss [2][4]. A negative result on these broader tests still does not rule out an immune-mediated illness, nor does it definitively prove you need a biopsy [2].

When a Brain Biopsy Might Be Considered

If your diagnosis remains uncertain, a multidisciplinary team—including neurology, neuroimmunology, neurosurgery, neuroradiology, infectious disease, and oncology specialists—will carefully evaluate your case [3]. They may discuss a biopsy if they encounter:

  • Suspected Tumors or Cancer: Conditions like primary CNS (central nervous system) lymphoma can look very similar to autoimmune encephalitis on an MRI [5]. While spinal fluid tests (like flow cytometry) and full-body imaging help, they do not always find the cancer [5]. If an MRI shows a mass-like lesion, a biopsy may be needed to confirm a tumor [6]. Important: Corticosteroids can hide signs of lymphoma on a biopsy, so your medical team must urgently coordinate the timing of your procedure and medications. Never stop prescribed steroids on your own.
  • Atypical or Unusual Infections: Certain rare fungal or bacterial infections can mimic autoimmune inflammation [7]. If non-invasive tests do not find an organism but an infection is strongly suspected, tissue from a biopsy can identify it and guide targeted antimicrobial treatment [7][3].
  • Unresolvable Mimics like CNS Vasculitis: Rare conditions such as CNS vasculitis (inflammation of the blood vessels in the brain) can cause similar brain scan abnormalities [8][9]. If non-invasive tests cannot distinguish this from encephalitis, a biopsy might be necessary to ensure you receive the correct treatment [9].
  • Unexpected Deterioration: If you do not improve after powerful immune-suppressing medications, it does not mean you automatically need a biopsy. Non-response can be due to delayed recovery, inadequate medication dosing, or irreversible injury [3]. However, lack of improvement will trigger a thorough reassessment. A biopsy is only considered if this re-evaluation identifies a suitable MRI target and raises a specific concern for an alternative diagnosis [3].

What a Biopsy Can and Cannot Tell You

It is critical to understand that a brain biopsy is not a reliable test to confirm or exclude autoimmune encephalitis itself [3]. Inflammatory changes in the brain can be patchy, non-specific, or entirely absent in a small sample. A normal or non-diagnostic tissue sample does not rule out autoimmune encephalitis [3].

Diagnostic Yield and Risks

A biopsy does not guarantee an answer. In research studies of patients with unexplained neurological diseases, biopsies provided a contributory diagnosis in roughly 42% to 69% of cases, and changed the treatment plan in about 25% to 77% of those cases [10][11][12]. The chances of a useful result are much higher when the MRI shows a clear, specific target (a visible lesion) [8][13].

These statistics are not individualized odds. Your specific risk depends heavily on the lesion’s size, its location (how deep it is in the brain), your overall health, and the surgical center’s experience [13]. Most modern biopsies are stereotactic (using precise 3D image guidance to insert a needle). While generally safe, potential complications include symptomatic bleeding in the brain (around 4% in some studies of unexplained illness), infection, seizures, or a worsening of neurological symptoms [12]. Severe complications, like permanent neurological harm or death, are very rare but possible (often cited as around 1% or less in carefully selected patients) [13].

What the Procedure Entails

If a biopsy is recommended, it typically involves general anesthesia and a short hospital stay for observation. The surgeon uses a stereotactic needle to take tiny samples of the targeted area. Preliminary pathology results might be available quickly, but specialized testing for infections, lymphoma, and specific inflammatory markers can take several days to weeks. If the sample is non-diagnostic, your team will have to reassess your treatment plan based on clinical judgment [3].

What This Means for You

A negative antibody result can be unsettling, but it does not by itself mean that a biopsy is needed [1]. Specialists use established clinical criteria to diagnose and treat probable seronegative patients using non-invasive tools [1][2]. If a biopsy is suggested, it means your care team is actively working to ensure they aren’t missing a treatable alternative condition that requires a completely different approach [3]. Whenever possible, seek a second opinion at a major neuroimmunology and neurosurgical center if a brain biopsy is being proposed for an uncertain diagnosis.

Note: If you experience a new or prolonged seizure, rapidly worsening confusion or consciousness, new weakness, or severe headache with fever, seek urgent medical advice. Do not alter your prescribed medicines without the guidance of your treating team.

Common questions in this guide

Does a negative autoimmune encephalitis antibody test mean I need a brain biopsy?
No. A negative antibody panel does not by itself mean that a biopsy is necessary; doctors usually assess the pattern and timing of symptoms, MRI, EEG, spinal fluid results, and other possible causes. More specialized paired blood and spinal fluid testing may be considered first.
When might doctors consider a brain biopsy for seronegative encephalitis?
A multidisciplinary team may consider it when a dangerous alternative diagnosis remains possible, such as a brain tumor, central nervous system lymphoma, unusual infection, or blood-vessel inflammation. It is more useful when MRI shows a specific lesion that can be safely sampled.
Can a brain biopsy confirm or rule out autoimmune encephalitis?
Not reliably. Inflammation can be patchy, nonspecific, or absent in a small tissue sample, so a normal or nondiagnostic biopsy does not rule out autoimmune encephalitis. The result must be interpreted with the clinical picture and other tests.
What are the chances that a brain biopsy will find the cause?
In studies of people with unexplained neurologic illness, a biopsy provided a contributory diagnosis in roughly 42% to 69% of cases and changed the treatment plan in about 25% to 77% of those cases. These figures are not personal odds; usefulness depends on the MRI target, its location, overall health, and the surgical center's experience.
What risks should I discuss before a brain biopsy?
Risks include bleeding, infection, seizures, and worsening neurologic symptoms; the level of risk depends on the lesion's size and location and your health. Severe permanent harm or death is very rare in carefully selected patients but remains possible, so ask about the center's results for lesions like yours.
Can steroids change the result of a brain biopsy?
Yes. Corticosteroids can hide signs of central nervous system lymphoma and may affect biopsy timing, so your specialists need to coordinate medications and the procedure. Do not stop or change prescribed steroids on your own.

Get notified when new evidence is published on Non-specific autoimmune supratentorial encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964
  2. 2

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  3. 3

    Mycobacterium celatum encephalitis in an immunocompromised host mimicking autoimmune striatal encephalitis: the first case report.

    Taweephol T, Pongpitakmetha T, Anukoolwittaya P, et al.

    BMC infectious diseases 2025; (25(1)):321 doi:10.1186/s12879-025-10602-5.

    PMID: 40050751
  4. 4

    Antibody-Negative Autoimmune Encephalitis: A Single-Center Retrospective Analysis.

    Mojžišová H, Krýsl D, Hanzalová J, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(6)) doi:10.1212/NXI.0000000000200170.

    PMID: 37879962
  5. 5

    Diagnosis of primary central nervous system lymphoma: a systematic review of the utility of CSF screening and the role of early brain biopsy.

    Morell AA, Shah AH, Cavallo C, et al.

    Neuro-oncology practice 2019; (6(6)):415-423 doi:10.1093/nop/npz015.

    PMID: 31832211
  6. 6

    Autoimmune Encephalitis-like Presentation of Glioblastoma: Get to Know This Rare Occurrence.

    Negro A, D'Agostino V, Covelli EM, et al.

    Journal of clinical medicine 2025; (14(11)) doi:10.3390/jcm14113807.

    PMID: 40507568
  7. 7

    Central Nervous System Infections Due to Aspergillus and Other Hyaline Molds.

    Miceli MH

    Journal of fungi (Basel, Switzerland) 2019; (5(3)) doi:10.3390/jof5030079.

    PMID: 31480311
  8. 8

    Diagnostic Value and Safety of Brain Biopsy in Patients With Cryptogenic Neurological Disease: A Systematic Review and Meta-analysis of 831 Cases.

    Bai HX, Zou Y, Lee AM, et al.

    Neurosurgery 2015; (77(2)):283-95; discussion 295 doi:10.1227/NEU.0000000000000756.

    PMID: 25856111
  9. 9

    A case of central nervous system vasculitis presenting as a mass-like lesion.

    Denny AM, Das SK

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2019; (35(7)):1223-1226 doi:10.1007/s00381-018-04034-7.

    PMID: 30610477
  10. 10

    Long-term utility and complication profile of open craniotomy for biopsy in patients with idiopathic encephalitis.

    Abdullah KG, Li Y, Agarwal P, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2017; (37()):69-72 doi:10.1016/j.jocn.2016.11.013.

    PMID: 27979652
  11. 11

    Early brain biopsy in neurological diseases of unknown etiology improves functional outcome.

    Aboubakr O, Mokhtari K, Nichelli L, et al.

    European journal of internal medicine 2026; (150()):106878 doi:10.1016/j.ejim.2026.106878.

    PMID: 41982007
  12. 12

    Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort study.

    van Steenhoven RW, Salih S, de Vries JM, et al.

    Annals of clinical and translational neurology 2025; (12(4)):792-804 doi:10.1002/acn3.70000.

    PMID: 39981762
  13. 13

    Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety.

    Mathon B, Le Joncour A, Bielle F, et al.

    European journal of internal medicine 2020; (80()):78-85 doi:10.1016/j.ejim.2020.05.029.

    PMID: 32654880

This page is for informational purposes only and does not constitute medical advice. Only your treating specialists can determine whether a brain biopsy is appropriate, and you should not change prescribed steroids or other medicines without their guidance.